Intellectus Partners LLC Raises Stock Holdings in UnitedHealth Group Inc (NYSE:UNH)

Intellectus Partners LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 29.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,711 shares of the healthcare conglomerate’s stock after buying an additional 615 shares during the quarter. Intellectus Partners LLC’s holdings in UnitedHealth Group were worth $589,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. North Star Investment Management Corp. purchased a new position in UnitedHealth Group during the 3rd quarter valued at $30,000. Griffin Asset Management Inc. purchased a new position in UnitedHealth Group during the 2nd quarter valued at $44,000. Coastal Capital Group Inc. purchased a new position in UnitedHealth Group during the 2nd quarter valued at $45,000. Capital Advisors Ltd. LLC increased its position in UnitedHealth Group by 235.7% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock valued at $57,000 after purchasing an additional 165 shares during the period. Finally, Next Capital Management LLC purchased a new position in UnitedHealth Group during the 2nd quarter valued at $61,000. 85.66% of the stock is currently owned by institutional investors.

A number of brokerages have issued reports on UNH. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $300.00 to $235.00 in a research report on Thursday. Deutsche Bank began coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They set a “hold” rating and a $263.00 price objective on the stock. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $283.22.

In related news, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $233.40, for a total transaction of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at approximately $43,874,298.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,000 shares of company stock worth $5,924,120. Company insiders own 0.87% of the company’s stock.

Shares of UNH stock opened at $222.07 on Friday. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94. The stock has a market cap of $210.45 billion, a PE ratio of 17.24, a price-to-earnings-growth ratio of 1.17 and a beta of 0.60. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The company’s fifty day moving average price is $227.16 and its 200-day moving average price is $240.09.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same quarter in the previous year, the business posted $3.14 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Inc will post 14.83 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Stock Ratings and Recommendations: Understanding Analyst Upgrades and Downgrades

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.